TY - JOUR T1 - Overall Survival Endpoint in Oncology Clinical Trials: Addressing the Effect of Crossover - The Case of Pazopanib in Advanced Renal Cell Carcinoma JO - Oncology UR - http://eprints.whiterose.ac.uk/111326/ PY - 2016/03/16 AU - Diaz J AU - Sternberg CN AU - Mehmud F AU - Delea TE AU - Latimer N AU - Pandite L AU - Motzer RJ ED - DO - DOI: 10.1159/000443647 VL - 90 IS - 3 SP - 119 EP - 126 Y2 - 2025/05/22 ER -